Article

Navigating CMC Requirements For Accelerated Development

Source: Lonza

By Jakob Bonde, Head of Regulatory Affairs, Small Molecules, and Jacqueline Hargis, Ph.D., Head of Supply Chain and Program Management, Lonza

iStock-1018468948-microscope-lab

INTRODUCTION

In pharmaceuticals, time is money, particularly when it comes to product launch. Experts estimate that launch delays can cost companies an average of $15 million per drug per day.1 Given the high stakes and competitive landscape, companies need to develop strategies early in the development process to minimize the possibility of launch delays and maximize speed to market, so crucial new therapies can reach patients quickly, patent life can be maximized, and market share can be enhanced.

Chemistry, manufacturing, and control (CMC) activities are critical to the effort of moving promising new drug products to market quickly and efficiently. This summary addresses how careful planning and early integration of an effective CMC strategy, plus choice of the right partner, contributes to project success. A case study is provided to show the results of effective use of these CMC strategies.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online